Abstract
There are several reports describing neutral aminopeptidase activities expressed in immune cells1–7. One of the best studied members of these enzymes is the Zn-dependent aminopeptidase N (CD13, E.C.3.4.11.2, APN) Within the hematopoietic system the expression of this leukocyte surface antigen was thought to be restricted to myelomonocytic cells 1,8,9. During recent years, it has been proven that lymphoid cells contain APN-mRNA and express corresponding enzymatic activity, too 2–4,7,10,11. These cells contain very low amounts of CD13 only, and therefore, are predominantly CD13-negative1,9,12,13. Recently, different groups have been provided conclusive evidence that CD13 is strongly induced during processes such as T cell activation or inflammation, suggesting that this antigen may well be involved in the regulation of proliferation and differentiation processes3,12,14–15.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Look, A.T., Ashmun, R.A., Shapiro, L.H., Peiper, S.C. (1989) Human Myeloid Plasma Membrane Glycoprotein CDI3 (gp150) is identical to Aminopeptidase N. J. Clin.invest. 83. 1299–1307.
Amoscato, A.A., Stramkowski, R.M., Babcock. G.F., Alexander, J.W. (1990) Neutral surface aminopeptidase activity of human tumour cell lines. Biochim. Biophys. Acta 1041(31, 317–319.
Ansorge, S., Schön, E., Kunz, D. (1991) Membrane-bound peptidases of lymphocytes: Functional implications. Biomed. Biochim. Acta 50 (4–6), 799–807.
Lendeckel, U., Wex, T., Kähne, T., Reinhold, D., Frank, K., Ansorge, S. (1994) Expression of the Aminopeptidase N (CD13) Gene in the Human T Cell Lines HuT78 and H9. Cell. Immunol. 153, 214–226.
Rautenberg, W. and Tschesche, H. (1984) Aminopeptidases from human leukocytes. Hoppe Seylers Z Physiol Chem. 365,49–58
Razak, K. and Newland, A.C. (1992) The Significance of Aminopeptidases and Hematopoietic Cell Differentation. Blood Rev. 6, 243–250.
Riemann, D., Schwachula, A., Hentschel, M., Langner, J. (1993) Demonstration of CD13/ aminopeptidase N on synovial fluid T cells from patients with different forms of joint effusions. Immunobiol. 187, 24–35.
Shipp, M.A. and Look, A.T. (1993) Hematopoietic Differentiation Antigens That Are Membrane-Associated Enzymes: Cutting Is the Key? Blood 82, 1052–1070.
Olsen, J., Laustsen, L., Kämström, U., Sjöström, H., Noren, O. (1991) Tissue-specific Interactions between Nuclear Proteins and Aminopeptidase N Promoter. J. Biol. Chem. 266 (27), 18089–96.
Riemann, D., Göhring, B., Langner, J. (1994) Expression of the aminopeptidase N/CDI3 in tumour-infiltrating lymphocytes from human renal cell carcinoma. Immunol. Lett. 42 (1 2), 19–23.
Wex, T., Lendeckel, U., Wex, H., Frank, K., Ansorge, S. (1995) Quantification of aminopeptidase N mRNA in T cells by competitive PCR. FEBS Lett. 374, 341–344.
Lendeckel, U., Wex, Th., Reinhold, D., Kähne, T., Frank, K.. Faust, J., Neubert, K., Ansorge, S. (1996) Induction of Membrane Alanyl Aminopeptidase Gene and Surface Expression in Human T Cells by Mito-genic Activation. Biochem. J. 319, 817–821.
Wex, Th., Lendeckel, U., Kähne, T., Ittenson, A., Frank, K., Ansorge, S. (1996) The Main Neutral Aminopeptidase Activity of Human Lymphoid Tumour Cell Lines Does Not Originate From The Aminopeptidase N- (APN; CDI3) Gene. Biochim. Biophys. Acta (in press).
Kunz, D., Bühling, F., Hütter, H.-J., Aoyagi, T., Ansorge, S. (1993) Aminopeptidase N (CDI3, E.C. 3.4.11.2) Occurs on the Surface of Resting and ConcanavalinA-stimulated Lymphocytes. Biol. Chem. Hoppe-Seyler 374, 291–296.
Riemann, D., Kehlen, A., Langner, J. (1995) Stimulation of the expression and the enzyme activity of aminopeptidase N/CDI3 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin. Exp. lmmunol. 100 (2). 277–283.
O’Connell, P.J., Gerkis, V., d’Apice, A.J.F. (1991) Variable 0-Glycosylation ofCDl3 (Aminopeptidase N). J. Biol. Chem 260, 4593–4597
Murray, H., Turner, A.J., Kenny, A.J. (1994) The aminopeptidase activity in the human T- cell lymphoma line (Jurkat) is not at the cell surface and is not aminopeptidase N (CD13). Biochem. J. 298, 353–360.
Belhacene, N., Mari, B., Rossi, B., Aubèrger, P. (1993) Characterisation and purification of T lymphocyte aminopeptidase B: a putative marker of T cell activation. Eur. J. Immunol. 23, 1948–1955.
Favaloro, E. J., Browning, T., Nandurkar, H., Sartor, M., Bradstock, K.F., Koutts, J. (1995) Aminopeptidasc-N (CDI3; GP 150): Contrasting patterns of enzymatic activity in blood from patients with myeloid or lymphoid leukemia. Leuk. Res. 19 (9), 659–666.
Saiki, I., Fujii, H., Yoneda, J., Abe, F., Nakajima, M., Tsuruo, T., Azuma, I. (1993) Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer 54, I37–143.
Imo, K., Goto, S., Okamoto, T., Nomura, S., Nawa, A., Isobe, K., Mizutani, S., Tomoda, Y. (1994) Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity. Jpn. J. Cancer Res. 85, 927–933.
Reinhold. D.. Bank, U., Bühling, F_ Kähne, T., Kunz, D., Faust, J., Neubert, K., Ansorge, S. (1994) Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. lmmunobiol. 19, 121–136.
McKenzie, R.C., Oran. A., Dinarello, C.A., Sauder, D.N. (1996) Interleukm-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo. Anticanc. Res. 16 (I), 437–441.
Jovcic, G., Ivanovic, Z., Biljanovic-Paunovic, L., Bugarski, D., Stosic-Grujicic, S., Milenkovic, P. 0996) In vivo effects of interlcukin-1 receptor antagonist on hematopoietic bone marrow progenitor cells in normal mice. Leukemia 10 (3), 564–569.
Chomarat, P., Rissoan, M.C., Pin, J.J., Banchereau, J., Miossec, R. (1995) Contribution of IL-1, CD14, and CDI3 in the increased 1L-6 production induced by in vitro monocyte-synoviocyte interactions. J Immunol 155 (7), 3645–3652.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wex, T. et al. (1997). Antisense-Mediated Inhibition of Aminopeptidase N (CD13) Markedly Decreases Growth Rates of Hematopoietic Tumour Cells. In: Ansorge, S., Langner, J. (eds) Cellular Peptidases in Immune Functions and Diseases. Advances in Experimental Medicine and Biology, vol 421. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9613-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9613-1_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9615-5
Online ISBN: 978-1-4757-9613-1
eBook Packages: Springer Book Archive